Proceedings of the National Academy of Sciences · 1992 · 65 citations · 36 references
Life SciencesImmunologyInfectious DiseasesMolecular VirologyVaccinologyVirologyAntiviral ImmunityViral InfectionsViral PathogenesisViral StructureViral VaccinesVirus-host InteractionsCell Surface ProteinsNeutralizationRna Virus BiologyStructural VirologyViral Envelope GlycoproteinsViral Envelope ProteinsViral GlycoproteinsViral Surface Proteins
Random insertion mutagenesis has been used to construct infectious Sindbis virus structural protein chimeras containing a neutralization epitope from a heterologous virus, Rift Valley fever virus. Insertion sites, permissive for recovery of chimeric viruses with growth properties similar to the parental virus, were found in the virion E2 glycoprotein and the secreted E3 glycoprotein. For the E2 chimeras, the epitope was expressed on the virion surface and stimulated a partially protective immune response to Rift Valley fever virus infection in vivo. Besides providing a possible approach for developing live attenuated vaccine viruses, insertion of peptide ligands into virion surface proteins may ultimately allow targeting of virus infection to specific cell types.
36
Phage antibodies: filamentous phage displaying antibody variable domains
John McCafferty, Andrew D. Griffiths, Greg Winter et al. · Nature · 1990 · 2.4K citations
Searching for Peptide Ligands with an Epitope Library
Jamie K. Scott, George P. Smith · Science · 1990 · 2.1K citations
Charles M. Rice, Robin Levis, James H. Strauss et al. · Journal of Virology · 1987 · 477 citations · Full text
David Baltimore · Nature · 1988 · 422 citations